Not applicableStudy completedNCT02429518
What this trial is testing
Dedicated QT Study in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis
Who this might be right for
Mucocutaneous Leishmaniasis
Knight Therapeutics (USA) Inc 42